Following its successful wide-spread live deployments around the world, Ibex sets new standards for Trusted-AI in cancer diagnostics to ensure high-impact cancer care For All
As a pioneer in AI-based cancer diagnostics, Ibex aims to address the global pathologist shortage and rising case complexity by acting as a digital assistant throughout the diagnostic process. Developed using a massive dataset of over 10 million slides, this clinical-grade platform works to reduce lab bottlenecks and help prevent diagnostic delays. By establishing these new standards for Trusted-AI, our team remains dedicated to ensuring high-impact, equitable cancer care for every patient.
The Ibex platform fits seamlessly into laboratory workflows
Available in multiple workflows:
- Supporting case review during primary diagnosis
- AI-powered second reads on all cases
Multi-tissue detection:
Prostate H&E, gastric H&E, breast H&E & IHC
AI-based diagnostic tools: prioritization, viewer, workflow optimization, cancer heatmaps, grading, measurements, non-cancer findings, AI-driven reporting
Open API: AI-integration with scanning, workflow and LIS systems; supports DICOM and ICC
Ibex partners with leading digital pathology providers worldwide
Ibex is revolutionizing anatomic pathology by putting the world’s most advanced AI-powered digital solutions directly into the hands of pathologists. Through strategic alliances with industry leaders in Laboratory Information Systems (LIS), Image Management Systems (IMS), and Whole Slide Imaging (WSI) Scanners, we ensure that laboratories can rapidly adopt and seamlessly integrate our clinical-grade tools into their existing workflows.
If you have a question about our partnerships or are interested in learning more about partnering with Ibex, please reach out to us: https://ibex-ai.com/partners/
